Corentec Co

Corentec Co EPS Growth

The EPS Growth of Corentec Co (104540.KQ) as of Nov 6, 2026 is 342.15 %. In the previous year, EPS Growth was -163.60 % — a change of -309.14% (higher).

EPS Growth

342.15 %

YoY

-309.14%

Last updated:

EPS Growth of Corentec Co is 2025 342.15 % . EPS Growth of Corentec Co was 2024 -163.60 % . It decreases by -309.14% higher compared to the previous year.

The Corentec Co EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2018
-303.36 KRW
Jan 1, 2019
107.90 KRW
Jan 1, 2020
-42.78 KRW
Jan 1, 2021
-52.31 KRW
Jan 1, 2022
123.32 KRW
Jan 1, 2023
120.41 KRW
Jan 1, 2024
-163.60 KRW
Jan 1, 2025
342.15 KRW
The Corentec Co EPS Growth history
YEAREPS GrowthYoY
342.15 %-309.14%
-163.60 %-235.86%
120.41 %-2.36%
123.32 %-335.77%
-52.31 %+22.26%
-42.78 %-139.65%
107.90 %-135.57%
-303.36 %-81.97%
-1,682.67 %-1,545.88%
116.38 %+181.12%
41.40 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co., Ltd. manufactures and sells artificial articulations, including hip, knee, and spine products. The company offers hip products under the BENCOX brand, featuring primary systems, hemi-arthroplasty systems, and revision systems such as cementless femoral stems and acetabular cups. Knee products are sold under the LOSPA brand, including fixed and mobile primary knee systems and revision systems. Spine products also carry the LOSPA IS brand, comprising pedicle screws and peek cages. Corentec distributes these products domestically and internationally, targeting healthcare providers and hospitals that require orthopedic solutions. The firm’s revenue comes from the sale of hip, knee, and spine products through its BENCOX, LOSPA, and LOSPA IS brand portfolios. Domestic and overseas markets are key segments, with the company focusing on orthopedic surgeons and medical institutions that purchase these specialized medical devices. Corentec’s product lines are designed for both primary and revision surgeries, catering to a broad range of orthopedic needs in the healthcare sector. Corentec Co., Ltd. serves healthcare providers globally, with its BENCOX brand dominating hip product sales and LOSPA/LOSPA IS covering knee and spine solutions. The company’s distribution strategy emphasizes direct sales to hospitals and medical centers, ensuring consistent product availability for surgical procedures. By maintaining distinct brand identities for each product category, Corentec efficiently targets specific medical specialties within the orthopedic market. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

EPS Growth of Corentec Co is 342.15 % in 2025.

On Eulerpool you can find the complete historical development of EPS Growth Corentec Co since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's Corentec Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Corentec Co

All Key Metrics — Corentec Co